Rgenta Therapeutics (Seed)

Funding Details
Awarder
Inbox
Date Award
April 04, 2020
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$20,000,000

Company Info
Founders
Dr. Simon Xi
Company Description
Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.
Market
Oncology and Neurological Disorders
Location
Cambridge, MA, USA
Coinvestors
Boehringer Ingelheim Venture Fund, Kaitai Capital, Legend Star, Matrix Partners

Links